About Aurealix
An independent research and technology initiative in the Netherlands.
Aurealix explores adaptive bioelectronic and biopharmaceutical technologies through scientific architecture, selective technology development, intellectual-property assessment, research software and staged experimental validation.
Research approach
Architecture before overclaiming.
Scientific frameworks are used to define questions and boundaries. Technical embodiments are assessed separately, and experimental evidence is treated as distinct from conceptual plausibility or software implementation.
Validation approach
Prospective and evidence-driven.
Aurealix prioritizes reproducibility, prospective testing, provenance, uncertainty and explicit validation before application-specific or clinical claims.
Collaboration
Research, technology and translation partners.
Aurealix welcomes dialogue with research institutes, universities, technology partners and clinical organisations where capabilities align with a focused validation question.